|
KIAA1958 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.60420000406125E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.33219999995682E-06 |
| Normal-vs-Stage2 |
2.983700E-03 |
| Normal-vs-Stage3 |
2.50449999628088E-08 |
| Normal-vs-Stage4 |
5.14050000344213E-08 |
| Stage1-vs-Stage2 |
5.174200E-01 |
| Stage1-vs-Stage3 |
1.116820E-01 |
| Stage1-vs-Stage4 |
2.812300E-02 |
| Stage2-vs-Stage3 |
8.013500E-02 |
| Stage2-vs-Stage4 |
3.647800E-02 |
| Stage3-vs-Stage4 |
5.045400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28839999949493E-07 |
| Normal-vs-AfricanAmerican |
4.087700E-02 |
| Normal-vs-Asian |
8.18079999964638E-07 |
| Caucasian-vs-AfricanAmerican |
2.188000E-01 |
| Caucasian-vs-Asian |
2.021600E-01 |
| AfricanAmerican-vs-Asian |
5.034000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18600004764369E-09 |
| Normal-vs-Female |
1.47340000000717E-06 |
| Male-vs-Female |
4.798400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81200000004544E-06 |
| Normal-vs-Age(41-60Yrs) |
1.66099999998615E-06 |
| Normal-vs-Age(61-80Yrs) |
8.70860000001805E-07 |
| Normal-vs-Age(81-100Yrs) |
1.096100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.912400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.094000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.903000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.652800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.515200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.482600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.840400E-03 |
| Classical-VS-Follicular |
3.693800E-01 |
| Classical-VS-Other |
3.137000E-01 |
| Classical-VS-Normal |
4.82180000371812E-08 |
| Tall-VS-Follicular |
1.088490E-02 |
| Tall-VS-Other |
9.798000E-01 |
| Tall-VS-Normal |
2.44690000483772E-08 |
| Follicular-VS-Other |
1.197820E-01 |
| Follicular-VS-Normal |
4.664700E-03 |
| Other-VS-Normal |
6.863900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61020000005929E-07 |
| Normal-vs-N1 |
1.55359999975957E-07 |
| N0-vs-N1 |
1.207630E-01 |
|
|
